The International Working Group discussed diagnosing Alzheimer's disease among cognitively unimpaired individuals in a ...

Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate ...

Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...

Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by ...

Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.

Italian researchers have developed a nasal spray showing promise in slowing Alzheimer's progression. Tests on mice with ...

Subtle signs of Alzheimer's disease can emerge decades before a diagnosis—often in the form of irregular behaviors that ...

A curious link between Alzheimer's and insulin resistance is now so well-established, the neurodegenerative disease is ...

I want to express my gratitude to Sen. Bob Casey for his steadfast dedication to the fight against Alzheimer’s disease during ...

"Alector stock drops after Alzheimer’s drug fails in Phase II trial" was originally created and published by Clinical Trials ...

A bill filed Tuesday morning at the Arkansas State Capitol could be a beacon of hope for many with loved ones battling ...